Title : [Drug therapy in subjects with impaired glucose tolerance].

Pub. Date : 1996 Oct

PMID : 8914439






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 New insulin sensitizers, such as troglitazone and pioglitazone, improve insulin-mediated glucose disposal by enhancing tissue sensitivity to the actions of insulin and reversing the insulin resistance, characteristic of NIDDM. Troglitazone insulin Homo sapiens
2 New insulin sensitizers, such as troglitazone and pioglitazone, improve insulin-mediated glucose disposal by enhancing tissue sensitivity to the actions of insulin and reversing the insulin resistance, characteristic of NIDDM. Troglitazone insulin Homo sapiens
3 New insulin sensitizers, such as troglitazone and pioglitazone, improve insulin-mediated glucose disposal by enhancing tissue sensitivity to the actions of insulin and reversing the insulin resistance, characteristic of NIDDM. Troglitazone insulin Homo sapiens
4 New insulin sensitizers, such as troglitazone and pioglitazone, improve insulin-mediated glucose disposal by enhancing tissue sensitivity to the actions of insulin and reversing the insulin resistance, characteristic of NIDDM. Troglitazone insulin Homo sapiens